September 26, 2025 Deadline: Join Class Action Lawsuit Against Sable Offshore Corp. (SOC) – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / August 6, 2025 / If you suffered a loss on your Sable Offshore Corp. (NYSE:SOC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sable-offshore-corp-lawsuit-submission-form?prid=159927&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or […]

First Quantum Minerals Announces Cash Tender Offer to Purchase Any and All of Its Outstanding 6.875% Senior Notes Due 2027

(TSX:FM), (In United States dollars, except where noted otherwise) TORONTO, Aug. 06, 2025 (GLOBE NEWSWIRE) — First Quantum Minerals Ltd. (the “Company” or “First Quantum”) (TSX: FM) today announced that it has commenced an offer to purchase for cash (the “Tender Offer”) any and all of its outstanding 6.875% Senior Notes due 2027 (the “Notes”)

First Quantum Minerals Announces Cash Tender Offer to Purchase Any and All of Its Outstanding 6.875% Senior Notes Due 2027

First Quantum Minerals Announces Cash Tender Offer to Purchase Any and All of Its Outstanding 6.875% Senior Notes Due 2027 GlobeNewswire August 06, 2025 (In United States dollars, except where noted otherwise) TORONTO, Aug. 06, 2025 (GLOBE NEWSWIRE) — First Quantum Minerals Ltd. (the “Company” or “First Quantum”) (TSX: FM) today announced that it has

Amadria Park Taps Shiji’s Daylight PMS and Infrasys POS to Drive Personalized Hospitality Across Croatia

Leading Croatian hotel group unifies operations and guest experiences with Shiji's cloud-native PMS and POS across multiple properties Shiji, the global hospitality technology leader, is proud to announce that Amadria Park, one of Croatia's premier hotel brands, has selected Daylight PMS and Infrasys Cloud POS to power its hotel operations across all properties. Known for

Bruker Corporation Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights – BRKR

NEW YORK, NY / ACCESS Newswire / August 6, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Bruker Corporation ("Bruker Corporation") (NASDAQ:BRKR) concerning possible violations of federal securities laws. On July 21, 2025, Bruker announced disappointing preliminary results for the second quarter, ended June 30, 2025. The Company disclosed

Kornit Digital Reports Second Quarter 2025 Results

(NASDAQ:KRNT), Second quarter revenues of $49.8 million, in line with previous guidance Second quarter GAAP net loss of $7.5 million; non-GAAP net income of $1.2 million Continued to generate cash from operations Reported annual recurring revenue from AIC contracts of $18.9 million, reflecting continued adoption of this new model, particularly from screen-printing customers. ROSH-HA`AYIN, Israel,

Arch Biopartners Announces First Patient Successfully Dosed at Toronto General Hospital in Phase II Trial of LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury

(TSX-V:ARCH),(OTC US:ACHFF),(Other OTC:ACHFF), First patient successfully completes dosing at Toronto General Hospital St. Michael's Hospital is expected to be the next Canadian clinical site activated Arch is looking for additional clinical sites in North America to join the trial TORONTO, Aug. 06, 2025 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture:

Kornit Digital Reports Second Quarter 2025 Results

Kornit Digital Reports Second Quarter 2025 Results GlobeNewswire August 06, 2025 Second quarter revenues of $49.8 million, in line with previous guidance Second quarter GAAP net loss of $7.5 million; non-GAAP net income of $1.2 million Continued to generate cash from operations Reported annual recurring revenue from AIC contracts of $18.9 million, reflecting continued adoption

Arch Biopartners Announces First Patient Successfully Dosed at Toronto General Hospital in Phase II Trial of LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury

Arch Biopartners Announces First Patient Successfully Dosed at Toronto General Hospital in Phase II Trial of LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury GlobeNewswire August 06, 2025 First patient successfully completes dosing at Toronto General Hospital St. Michael's Hospital is expected to be the next Canadian clinical site activated Arch is looking for additional

Scroll to Top